Center of Excellence for Head and Neck Cancer

Head and neck cancers are complex diseases. They affect various structures of the mouth, jaw, and throat. For the best care and to preserve these delicate structures, you need a team of experts. The Mount Sinai Health System is recognized throughout the world for our head and neck specialists and cutting-edge treatments. We work as a team to give you the most advanced and compassionate care possible. Mount Sinai’s Head and Neck Institute – Center of Excellence for Head and Neck Cancer offers robotic and minimally invasive treatments and the most current options for immunotherapy and clinical trials.

Our experts treat:

  • Larynx cancer
  • Oral cancer
  • Parathyroid cancer
  • Salivary gland disorders and cancer
  • Sinus cancer
  • Skin cancers of the face
  • Throat cancer
  • Thyroid disorders and cancer
  • Tracheal cancer 

Meet Our Team

The Center of Excellence for Head and Neck Cancer is co-led by Eric M. Genden, MD, Chair of the Department of Otolaryngology–Head and Neck Surgery, and Director of the Head and Neck Institute – Center of Excellence for Head and Neck Cancer, and Marshall Posner, MD. Director of Head and Neck Medical Oncology Dr. Genden was the first to perform transoral robotic surgery (TORS) for oropharyngeal cancers in New York in 2009. Dr. Posner is an expert in clinical and translational research in head and neck cancers, HIV, and immunity, as well as virally-caused head and neck cancers.

Team members include:

  • Head and neck surgeons
  • Microvascular and reconstructive surgeons
  • Oral and maxillofacial surgeons
  • Medical and radiation oncologists
  • Oncology nurse practitioners and nurses
  • Speech and hearing therapists
  • Social workers
  • Nutritionists 

A coordinator with our Patient First Program works with you, the multidisciplinary team, and your referring physician to coordinate your care and approach for your treatment.

Innovative Head and Neck Cancer Research

Mount Sinai offers you and your loved one access to the latest therapies through clinical trials. Physicians and researchers at our Head and Neck Cancer Research Program, are studying immunotherapies, reduction of medical oncology after transoral robotic surgery (TORS), transmission of human papillomavirus (HPV) and its effect on oropharyngeal cancers, reduction in side effects, quality of life with TORS versus open surgery, and correlation of environmental toxins and thyroid cancer. Our distinguished research program is internationally recognized as a leading resource for tumor cell dormancy research.

Why Choose Mount Sinai for Head and Neck Cancer Care

At Mount Sinai, our patients have the following distinct care advantages:

  • Expert minimally- invasive head and neck surgeons
  • State-of-the-art technology, including transoral robotic surgery (TORS) and sialendoscopy
  • Microvascular, reconstructive and oral and maxillofacial surgeons
  • Unmatched experience with HPV-related oropharyngeal cancers
  • Multidisciplinary team approach 
  • Medical and Radiation Oncology Surveillance Program during and after treatment
  • Participation in clinical trials, as appropriate
  •  Easy access to care, including participation in most insurance plans

To make an appointment you can do one of the following: